AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10337859
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 160 mg orally daily (TU)
Trial: 7202826
Drug: Indobufen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen (3 single oral doses)
Trial: 7202826
Drug: Indobufen (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen (same dose)
Trial: 7202826
Drug: Indobufen (increasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen (increasing doses)
Trial: 22040521
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (VPA, sodium valproate, 1000 mg once daily)
Trial: 17449576
Drug: Psyllium (7.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (7.28 g) and plant sterols (2 g)
Trial: 2719896
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg buccal morphine
Trial: 835542
Drug: Chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chenodeoxycholic acid 500 mg
Trial: 835542
Drug: Chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chenodeoxycholic acid 750 mg
Trial: 835542
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg)
Trial: 31136549
Drug: Red Spinach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Spinach Extract (RSE) 1 g daily for 7 days
Trial: 27861932
Drug: Swallow therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swallow therapy interventions
Trial: 24195839
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture and Naproxen Sustained Release Tablets
Trial: 11446878
Drug: Rabeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (10 mg b.i.d.) with amoxicillin (500 mg t.i.d.)
Trial: 10209375
Drug: Intravenous tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tenoxicam 20 mg
Trial: 7600216
Drug: PUVA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVA therapy (8‐methoxypsoralen 0.6 mg/kg administered orally 2 hours before irradiation)
Trial: 365428
Drug: Prazosin (17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (17 mg) substituted for methyldopa
Trial: 11767208
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate (SPI) 20 g per day for 4 weeks
Trial: 11767208
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate (SPI) 20 g per day with vitamin E 200 mg per day for 3 weeks
Trial: 11767208
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate (SPI) 20 g per day for 3 weeks
Trial: 9284857
Drug: Intravenous bumetanide
RxNorm normalized name: Bumetanide
DrugBank: Bumetanide (DB00887)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous bumetanide 3.25 mg at 0 hours and again at 6 hours
Trial: 9284857
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of bumetanide 0.5 mg/hr for 6 hours
Trial: 9284857
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 0.5 mg bumetanide at 0 hours followed by a bolus regimen
Trial: 31957130
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (MT) session before procedure
Trial: 31957130
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Music Therapy)
Trial: 29999194
Drug: Muffins with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muffins with 20 g flaxseed
Trial: 29999194
Drug: Muffins with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muffins with 30 g flaxseed
Trial: 29999194
Drug: Muffins with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muffins with 0 g flaxseed
Trial: 28327983
Drug: Coil embolization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coil embolization with adjunctive techniques (e.g., balloon remodeling)
Trial: 21175801
Drug: Intragastric infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intragastric infusion of 300 mL of 0.1 mol/L hydrochloric acid
Trial: 12686509
Drug: Water infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water infusion (control)
Trial: 17485422
Drug: Conventional disease-modifying
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional disease-modifying antirheumatic drugs (DMARDs)
Trial: 15152293
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no nicorandil treatment)
Trial: 12466679
Drug: Clonidine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.1 mg every 6 h, with one dose on-site each day and others taken home)
Trial: 12466679
Drug: Buprenorphine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.3 mg IM daily)
Trial: 2560555
Drug: RU 486
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 486 (glucocorticoid antagonist)
Trial: 17545717
Drug: Fosamprenavir/ritonavir 1400/200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosamprenavir/ritonavir 1400/200 mg once a day plus TDF 300 mg once a day
Trial: 11468730
Drug: Continuous IFNalpha‐n1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IFNalpha‐n1 therapy (group 2)
Trial: 11468730
Drug: Standard IFNalpha‐n1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard IFNalpha‐n1 therapy (group 3)
Trial: 11468730
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy (group 1)
Trial: 9875905
Drug: PAFra (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAFra (120 mg iv every 12 hrs over a 4-day period)
Trial: 2647818
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy (OIT) with freeze-dried birch-pollen antigens for 18 months, cumulative dose of 280 x 10(6) biologic units
Trial: 27670203
Drug: Dexchlorpheniramine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexchlorpheniramine plus betamethasone (three daily doses for 7 days)
Trial: 27670203
Drug: Desloratadine plus
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine plus prednisolone (single dose followed by two of placebo for 7 days)
Trial: 26305866
Drug: Non-aspirin NSAID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-aspirin NSAID use
Trial: 21640518
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy with chemotherapy (RT-CHT)
Trial: 11403243
Drug: Traditional outpatient
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional outpatient therapy (Home group, n = 10)
Trial: 3420976
Drug: PDEV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDEV vaccine
Trial: 4081704
Drug: HDCV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDCV vaccine
Trial: 8036825
Drug: PDEV and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDEV and HDCV vaccines
Trial: 30910489
Drug: Nonanimal hyaluronic
RxNorm normalized name: nonanal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonanimal hyaluronic acid (NASHA) 1 mL intra-articular injection
Trial: 18422164
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) nasal spray < or =400 microg/d
Trial: 18422164
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) nasal spray 1 ‐ <3 year
Trial: 18422164
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) nasal spray 3 ‐ <5 year
Trial: 18422164
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) nasal spray > or =5 year
Trial: 9516030
Drug: Acetaminophen 2
RxNorm normalized name: acetaminophen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 2 g
Trial: 12651647
Drug: Control (Vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Vitamin C 500 mg)
Trial: 11185633
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg plus Telmisartan 120 mg
Trial: 8348256
Drug: Ketotifen (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (0.5 mg for children younger than one year and 1 mg for older children)
Trial: 24768240
Drug: Baerveldt Glaucoma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baerveldt Glaucoma Implant (BGI)
Trial: 10706930
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy
Trial: 332349
Drug: Cyclic combination
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic combination chemotherapy (50 patients)
Trial: 332349
Drug: Cyclic combination
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic combination chemotherapy with total‐body irradiation (34 patients)
Trial: 332349
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy (34 patients)
Trial: 15163505
Drug: Monovalent aluminum-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent aluminum-adjuvanted whole virus formulations with 1.9 microg HA per dose
Trial: 15163505
Drug: Monovalent aluminum-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent aluminum-adjuvanted whole virus formulations with 3.75 microg HA per dose
Trial: 15163505
Drug: Monovalent aluminum-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent aluminum-adjuvanted whole virus formulations with 7.5 microg HA per dose
Trial: 15163505
Drug: Split virus
RxNorm normalized name: INFLUENZA SPLIT VIRUS '95-'96 VIL 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split virus vaccine (15 microg HA per dose) without aluminum adjuvantation
Trial: 15934094
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (500 mg/day)
Trial: 14615670
Drug: Effective treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective treatment of GERD with prolonged and aggressive antisecretory therapy
Trial: 10387955
Drug: Ibuprofen with
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen with organic acids as excipients in enteric matrix granules (Eudragit S and Aqoat AS-HF)
Trial: 10387955
Drug: Bioavailability tests
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioavailability tests
Trial: 10387955
Drug: Mathematical transformation
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mathematical transformation of data for individual formulations
Trial: 7201812
Drug: Bronchoretard (350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoretard (350 mg theophylline in capsule)
Trial: 22350624
Drug: Clopidogrel pre-treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel pre-treatment within 5 days prior to surgery
Trial: 17173912
Drug: RF-NaP (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RF-NaP (32 tablets, split dosing, 4 every 15 minutes)
Trial: 17173912
Drug: RF-NaP (28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RF-NaP (28 tablets, split dosing, 4 every 15 minutes)
Trial: 15179409
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g Hypericum powder with comparable hyperforin content
Trial: 11472387
Drug: Metamizol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizol 0.5 g
Trial: 23545707
Drug: losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 100 mg daily
Trial: 16432441
Drug: Comparison conditions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison conditions (routine care or another treatment)
Trial: 11081322
Drug: Trimetazidine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (3 x 20 mg/day for 24 hours prior to exercise test)
Trial: 15995772
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug administered)
Trial: 9121852
Drug: Budesonide 600
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 600 mu g twice daily
Trial: 1537130
Drug: Pimobendan 5
RxNorm normalized name: pimobendan 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimobendan 5 mg/day
Trial: 1537130
Drug: Pimobendan 10
RxNorm normalized name: pimobendan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimobendan 10 mg/day
Trial: 1537130
Drug: Pimobendan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimobendan (all doses combined)
Trial: 6714792
Drug: Cyclotropium bromide
RxNorm normalized name: Potassium Bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclotropium bromide (60 mg)
Trial: 6714792
Drug: Hyoscine N-butylbromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine N-butylbromide (60 mg)
Trial: 29327602
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (ESWT) with 2000 shock waves at 0.02 mJ/mm2 for 3 sessions, once a week.
Trial: 26823210
Drug: FF 100
RxNorm normalized name: APAP 325/CAFF 100/ISOMETHEPTENE 65MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF 100 μg in the morning (AM)
Trial: 26823210
Drug: FF 100
RxNorm normalized name: APAP 325/CAFF 100/ISOMETHEPTENE 65MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF 100 μg in the evening (PM)
Trial: 21040188
Drug: Slow up-titration
RxNorm normalized name: Slow-Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow up-titration with paroxetine (increments of 2.5 mg/day every 2 days)
Trial: 18949779
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil in combination with prednisone
Trial: 16288373
Drug: HPV-6 L2E7
RxNorm normalized name: Adxs hpv
DrugBank: Axalimogene filolisbac (DB16692)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-6 L2E7 vaccine with AS02A adjuvant
Trial: 11923135
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment variation
Trial: 28272808
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care treatment for HF
Trial: 26275648
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg/day, up titrated to 2 g/day
Trial: 23852294
Drug: Polyherbal formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyherbal formulation (PHF)
Trial: 23811465
Drug: Herbal medicine
RxNorm normalized name: Herbal medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal medicine treatment
Trial: 8770380
Drug: Bronchoconstriction provoked
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchoconstriction provoked by allergic agents
Trial: 1308247
Drug: 75 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/kg Triclofos elixir (Regimen I)
Trial: 29500585
Drug: Oxazepam 10
RxNorm normalized name: oxazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 10 mg (OXA10)
Trial: 29500585
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg (DIA10)
Trial: 29500585
Drug: Oxazepam 30
RxNorm normalized name: oxazepam 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 30 mg (OXA30)
Trial: 16194202
Drug: Ximelagatran (24-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran (24-60 mg b.i.d)
Trial: 11807406
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy for X‐linked severe combined immunodeficiency (SCID‐X1)
Trial: 1686339
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tetrazepam and a nonsteroid analgetic
Trial: 26347428
Drug: Language for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Language for Learning intervention (18 1-hour home-based therapy sessions)
Trial: 23472619
Drug: 20-mg memantine
RxNorm normalized name: memantine hydrochloride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg memantine
Trial: 7941992
Drug: Radiation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation treatment (external beam photon treatment of the whole pelvis, average total dose of 3680 cGy rad)
Trial: 31578771
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg once daily for 6 weeks
Trial: 10570555
Drug: Topical terbinafine
RxNorm normalized name: terbinafine Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical terbinafine
Trial: 11682403
Drug: Remifentanil 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 10 microg plus propofol 5 mg
Trial: 9322450
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) 80 mg/kg intravenously in divided doses
Trial: 3361096
Drug: Training group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training group that received formal instructions in principles underlying figural relations problem solution (n = 24)
Trial: 30928180
Drug: 40IU intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40IU intranasal oxytocin
Trial: 19230772
Drug: Azacitidine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azacitidine (75 mg/m² per day for 7 days every 28 days)
Trial: 19230772
Drug: Conventional care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional care (best supportive care, low-dose cytarabine, or intensive chemotherapy)
Trial: 17029304
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml 0.9% saline (placebo)
Trial: 10947034
Drug: Melatonin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (0.1 mg)
Trial: 11422884
Drug: Melatonin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (all doses)
Trial: 25387601
Drug: Cetuximab plus
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab plus chemotherapy (armA)
Trial: 23228201
Drug: Lithium 0.6‐1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium 0.6‐1.2 mEq/L
Trial: 23228201
Drug: Lithium <0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium <0.6 mEq/L
Trial: 18245031
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) internet intervention
Trial: 16155359
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin E supplementation (600 mg/day)
Trial: 12882653
Drug: NRTI-only therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRTI-only therapy
Trial: 10371242
Drug: 0.03 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 mg/kg triazolam (Halcion)